Combinations ; See Below
1. Adsorbed Diphtheria(Low dose)/Tetanus/Polio(inactive)
2. Diphtheria, Adsorbed Tetanus, Pertusis(Acellular)Inactivated Polio
3. DTP/Polio injectable/Haemophilia B
4. DTP/Polio/Haemophilia B
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| DT vax | Sanofi Ltd. | Sanofi Ltd | 10dose / Vial | KES 1,000 | |||
| Trintanrix | GSK | 1 dose | KES 556 |
| Diphtheria, Tetanus Vaccine More info | |
|---|---|
| Mode Of Action | excite immune system to produce antibodies corresponding to the vaccine antigen |
| Drug Indication | Active immunization against diphtheria and tetanus |
| Dosage | Children aged 6wks: at 6th, 10th and 14th wks. Adult: 3 injections one month apart. Booster every 10 yrs |
| Drug Category | DRUGS ACTING ON INFECTIONS |
| Drug Sub-Category | Vaccines |
Combinations ;
| 1. Adsorbed Diphtheria [low dose], Tetanus and Poliomyelitis (Inactivated) Vaccine | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mode Of Action | excite immune system to produce antibodies corresponding to the vaccine antigen |
||||||||||||||||||||||||
| Dosage | I.M., adult and child over 10 years, primary immunisation, 3 doses each of 0.5mL separated by intervals of 1 month; second booster dose, 0.5mL given 10 years after first booster dose (may also be used as first booster dose in those over 10 years who have received only 3 previous doses of a diphtheria-containing vaccine) | ||||||||||||||||||||||||
| Drug Category | DRUGS ACTING. ON INFECTIONS | ||||||||||||||||||||||||
| Drug Sub-Category | Vaccine
|
||||||||||||||||||||||||
2. Diphtheria, Adsorbed Tetanus, Pertusis(Acellular)Inactivated Polio
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Tetraxim | Sanofi Ltd. | 1 dose syringe | KES 1,708 | ||||
| Hexavac | Sanofi | 1 dose syringe | KES 1 |
3. DTP/Polio injectable/Haemophilia B
children aged more than 6 weeks; at 6th, 10th, and 14th wks. Booster at 12-18weeks.
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Infantrix vial | GSK Ltd. | 1 dose vial | KES 1,273 | ||||
| Infantrix Hexa | GSK | 1 dose vial | KES 3,290 |
4. DTP/Polio/Haemophilia B
Dosage ; 3 dose injections 1 or 2 months interval from 2 month of age followed by a booster injection during the second year of life
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Pentaxim | Sanofi Ltd. | 1 dose vial | KES 2,770 | ||||
| Pentact HiB | Sanofi LTD | 1 dose syringe | KES 1,048 |
| 5. Diphtheria / Tetanus / Pertussis / Hepatitis B vaccine | |
|---|---|
| Mode Of Action | excite immune system to produce antibodies corresponding to the vaccine antigen |
| Drug Indication | active immunisation against diphtheria, tetanus, pertussis and hepatitis B (HBV) in infants from 6 weeks onwards. |
| Precautions | Temperature of 400C within 48 hours, not due to another identifiable cause, collapse or shock-like state within 48 hours, persistent crying lasting 3 hours, occurring within 48 hours, convulsions with or without fever, occurring within 3 days. |
| Contra-Indications | Hypersensitivity to the active substances or to any of the excipients, acute severe febrile illness. |
| Side Effects | Pain, redness or swelling at injection site, fever (more than 38C), drowsiness, irritability, unusual crying, feeding problems. |
| Dosage | 0.5mL, three vaccine doses administered at intervals of at least 4 weeks. |
| Drug Category | DRUGS ACTING ON INFECTIONS |
| Drug Sub-Category | Vaccines |
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Tritanrix Hep B | Sanofi Ltd. | 1 dose syringe | KES 630 | ||||